Evidence map›Paper›PMID 41059452›Full record

ArticleMolecular syndromology2025

A Family of

Esra Dirimtekin, Çekdar Kapazan, Barış Yılmaz, Ahmet Mert Yanık, Bilgen Bilge Geckinli

Abstract read
In one paragraph

Article in Molecular syndromology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Esra DirimtekinDepartment of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.
Çekdar KapazanDepartment of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.
Barış YılmazDepartment of Pediatric Hematology Oncology, Marmara University, Pendik Education and Research Hospital, Istanbul, Turkey.
Ahmet Mert YanıkDepartment of Hematology Oncology, Marmara University, Pendik Education and Research Hospital, Istanbul, Turkey.
Bilgen Bilge GeckinliDepartment of Medical Genetics, School of Medicine, Marmara University, Istanbul, Turkey.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: The lamin-B receptor (LBR) gene has two primary functions: maintaining the structural integrity of the nuclear envelope and playing a role in cholesterol biosynthesis. Heterozygous variants in the LBR gene have been associated with Pelger-Huët anomaly (PHA, OMIM #169400), while homozygous or compound heterozygous mutations have been associated with rhizomelic skeletal dysplasia, with or without PHA (OMIM #618019) and Greenberg dysplasia (OMIM #215140). Case Presentation: We report a 4-year-old boy presenting with short stature and short limbs and his mother exhibiting milder findings. Genetic analysis revealed a heterozygous c.1640A>G (p.Asn547Ser) and c.43C>T (p.Arg15*) variants in the Conclusion: The phenotypic differences observed between the mother and male child in our study highlight the genetic variability and regressive nature of LBR-related skeletal dysplasias. This report shows the complexity of

Indexed as

Greenberg dysplasiaLBRPelger-Huët anomalyRhizomelic shorteningSkeletal dysplasia

Identifiers

PMID41059452
PMCPMC12500306

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.